CONMED Corp. (CNMD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1251172,
    "name": "CONMED Corp.",
    "stock_name": "CONMED Corp.",
    "full_name": "CONMED Corp.",
    "name_url": "stocks-analysis/conmed-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "44.24",
    "chg": -0.11,
    "chgp": "-0.25%",
    "dir": -1,
    "prev_price": "44.35",
    "mcapval": "1,777.43",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US2074101013",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "216.59 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/conmed-corp-1251172-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "CONMED Corp. Stock Plummets to New 52-Week Low of $42.50",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/conmed-corp-stock-plummets-to-new-52-week-low-of-4250-3617556",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CONMEDCorp_priceRelatedfactors_3617556.png",
        "date": "2025-10-13 17:22:56",
        "description": "CONMED Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,777 million, faces challenges in growth and profitability, evidenced by a notable decrease in net profit and ongoing scrutiny from institutional investors."
      },
      {
        "title": "CONMED Corp. Hits New 52-Week Low at USD 45.11 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/conmed-corp-hits-new-52-week-low-at-usd-4511-amid-decline-3574385",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CONMEDCorp_priceRelatedfactors_3574385.png",
        "date": "2025-09-26 14:58:14",
        "description": "CONMED Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,777 million, faces challenges in growth despite high institutional holdings and a notable dividend yield. Its financial metrics indicate a fair valuation relative to assets."
      },
      {
        "title": "Is CONMED Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-conmed-corp-technically-bullish-or-bearish-3545085",
        "imagepath": "",
        "date": "2025-09-20 19:03:18",
        "description": "As of 1 August 2025, the technical trend for CONMED Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but remains bearish on the monthly. The RSI indicates no signal on both weekly and monthly timeframes. Bollinger Bands and moving averages are bearish, while KST shows a mildly bullish signal weekly but is bearish monthly. Dow Theory presents a mildly bearish stance weekly and mildly bullish monthly. \n\nIn terms of performance, CONMED has significantly underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -24.87% compared to the S&P 500's 12.22%, and a one-year return of -32.35% against the S&P 500's 17.14%...."
      },
      {
        "title": "Is CONMED Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-conmed-corp-overvalued-or-undervalued-3541811",
        "imagepath": "",
        "date": "2025-09-20 17:36:53",
        "description": "As of 30 June 2025, CONMED Corp. has moved from a fair to attractive valuation grade. The company appears to be undervalued, with a P/E ratio of 21, an EV to EBITDA of 13.82, and a Price to Book Value of 1.92. In comparison to peers, Globus Medical, Inc. has a P/E of 18.37, while Sanmina Corp. shows a much higher P/E of 39.80, indicating that CONMED may offer better value relative to these competitors.\n\nHowever, it's important to note that CONMED has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -24.87% compared to the S&P 500's 12.22%. This significant underperformance may raise concerns about the company's growth prospects despite its attractive valuation metrics...."
      }
    ],
    "total": 9,
    "sid": "1251172",
    "stock_news_url": "https://www.marketsmojo.com/news/conmed-corp-1251172"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

CONMED Corp. Stock Plummets to New 52-Week Low of $42.50

2025-10-13 17:22:56

CONMED Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,777 million, faces challenges in growth and profitability, evidenced by a notable decrease in net profit and ongoing scrutiny from institutional investors.

CONMED Corp. Hits New 52-Week Low at USD 45.11 Amid Decline

2025-09-26 14:58:14

CONMED Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 1,777 million, faces challenges in growth despite high institutional holdings and a notable dividend yield. Its financial metrics indicate a fair valuation relative to assets.

Is CONMED Corp. technically bullish or bearish?

2025-09-20 19:03:18

As of 1 August 2025, the technical trend for CONMED Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but remains bearish on the monthly. The RSI indicates no signal on both weekly and monthly timeframes. Bollinger Bands and moving averages are bearish, while KST shows a mildly bullish signal weekly but is bearish monthly. Dow Theory presents a mildly bearish stance weekly and mildly bullish monthly. In terms of performance, CONMED has significantly underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -24.87% compared to the S&P 500's 12.22%, and a one-year return of -32.35% against the S&P 500's 17.14%....

Is CONMED Corp. overvalued or undervalued?

2025-09-20 17:36:53

As of 30 June 2025, CONMED Corp. has moved from a fair to attractive valuation grade. The company appears to be undervalued, with a P/E ratio of 21, an EV to EBITDA of 13.82, and a Price to Book Value of 1.92. In comparison to peers, Globus Medical, Inc. has a P/E of 18.37, while Sanmina Corp. shows a much higher P/E of 39.80, indicating that CONMED may offer better value relative to these competitors. However, it's important to note that CONMED has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -24.87% compared to the S&P 500's 12.22%. This significant underperformance may raise concerns about the company's growth prospects despite its attractive valuation metrics....

View All News